differences between semaglutide and tirzepatide Tirzepatide: Key Explained Understand the Difference between Semaglutide

[1] Incretins such as GLP-1 inhibit glucagon release from the alpha cells of the islets of Langerhans

GLP-1 acts locally in the GI tract and via the vagus nerve, a key autonomic pathway that, when activated, further slows stomach emptying

Animal model studies have suggested that GLP-1RAs may cause pancreatitis and exocrine dysplasia, but in the large RCTs and a meta-analysis, GLP-1RAs did not increase the risk of pancreatitis or pancreatic cancer [82,83]

Proper titration is not optional

It remains under Phase 3 clinical investigation

This is also the dose used for type 2 diabetes management under the Ozempic brand, and it represents the point where semaglutide is working at full therapeutic strength for blood sugar control